Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
compounded under Section 503A pharmacy rules Typical research dose / 250-500 mcg subcutaneous injection once daily Lethal dose in humans / none reported in published literature as of May 2026 GH-receptor activation / absent at standard and supra-pharmacologic doses per Heffernan et al
Users often report improved stamina, reduced fatigue, and better physical performance, though these subjective reports have not been validated in controlled human trials
Hydroxocobalamin injection: Product information
At the molecular level, chronic AOD9604 administration upregulates 3 adrenergic receptors in fat tissue, reversing obesityrelated suppression of these fatburning receptors [9]
US$ 23.97
US$ 29.49
US$ 28.33
US$ 27.24
